Table 5.
Treatment | Status | EM/EM (baseline) |
EM/IM | IM/IM | EM/PM | PM/IM | PM/PM | Missing Genotype data |
---|---|---|---|---|---|---|---|---|
Tamoxifen | Controls | 243 | 86 | 8 | 195 | 29 | 32 | 2 |
Cases | 129 | 46 | 4 | 97 | 23 | 16 | 3 | |
Odds Ratio | 1 | 0.994 | 1.096 | 0.947 | 1.461 | 0.895 | ||
95% CI | - | (0.651–1.518) | (0.309–3.889) | (0.677–1.325) | (0.787–2.711) | (0.462–1.736) | ||
p-value | - | 0.979 | 0.888 | 0.75 | 0.229 | 0.743 | ||
Raloxifene | Controls | 226 | 61 | 4 | 175 | 34 | 28 | 3 |
Cases | 107 | 47 | 4 | 72 | 22 | 21 | 0 | |
Odds Ratio | 1 | 1.671 | 2.417 | 0.87 | 1.321 | 1.597 | ||
95% CI | - | (1.052–2.653) | (0.513–11.379) | (0.605–1.25) | (0.747–2.335) | (0.872–2.924) | ||
p-value | - | 0.03 | 0.264 | 0.451 | 0.338 | 0.129 | ||
Total | Controls | 469 | 147 | 12 | 370 | 63 | 60 | 5 |
Cases | 236 | 93 | 8 | 169 | 45 | 37 | 3 | |
Odds Ratio | 1 | 1.257 | 1.566 | 0.916 | 1.386 | 1.213 | ||
95% CI | - | (0.922–1.713) | (0.601–4.085) | (0.717–1.171) | (0.914–2.103) | (0.778–1.891) |